TARDBP and amyotrophic lateral sclerosis: All in all, SOD and TDP-43-based ALS preclinical models do not generally alter nucleoporin content in whole lysates of the spinal cord, albeit they show increased Tfeb that may contribute to lysosome-based autophagic compensations.